(University of Chicago Medical Center) Identifying molecular pathways that boost the immune response to tumor neoantigens opens up new ways to develop and amplify cancer immunotherapy.
from EurekAlert! - Technology, Engineering and Computer Science http://bit.ly/2WNL9Lx
Thursday, February 7, 2019
Nullifying protein YTHDF1 enhances anti-tumor response
About Engr. Abbas Yousfzai -
Author Description here.. Nulla sagittis convallis. Curabitur consequat. Quisque metus enim, venenatis fermentum, mollis in, porta et, nibh. Duis vulputate elit in elit. Mauris dictum libero id justo.